
1. Microb Genom. 2021 Nov;7(11). doi: 10.1099/mgen.0.000684.

Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the
pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or
B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms.

Barona-Gómez F(1), Delaye L(2), Díaz-Valenzuela E(1), Plisson F(3), Cruz-Pérez
A(1), Díaz-Sánchez M(4), García-Sepúlveda CA(5), Sanchez-Flores A(6), Pérez-Abreu
R(7), Valencia-Valdespino FJ(8), Vega-Magaña N(9), Muñoz-Valle JF(10),
García-González OP(4), Bernal-Silva S(11), Comas-García A(11)(5),
Cibrián-Jaramillo A(1).

Author information: 
(1)Unidad de Genómica Avanzada (Langebio), Cinvestav-IPN, Irapuato, Guanajuato,
Mexico.
(2)Departamento de Ingeniería Genética, Unidad Irapuato, Cinvestav-IPN, Irapuato,
Guanajuato, México.
(3)Conacyt - Unidad de Genómica Avanzada (Langebio), Cinvestav-IPN, Irapuato,
Guanajuato, México.
(4)Molecular Biology Research & Development Department, GrupoT, Irapuato,
Guanajuato, México.
(5)Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis, San
Luis Potosí, México.
(6)Instituto de Biotecnología, Universidad Nacional Autónoma de México,
Cuernavaca, Morelos, México.
(7)Centro de Investigación en Matemáticas AC (Cimat), Sede Aguascalientes,
Aguascalientes, México.
(8)Prothesia, Monterrey, Nuevo Leon, México.
(9)Laboratory for the Diagnosis of Emerging and Reemerging Diseases (LaDEER),
University Center for Health Sciences, University of Guadalajara, Guadalajara,
Jalisco, México.
(10)Institute for Research in Biomedical Sciences, University Center for Health
Sciences, University of Guadalajara, Guadalajara, Jalisco, México.
(11)Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad
Autónoma de San Luis Potosí, San Luis, San Luis Potosí, México.

Understanding the evolution of the SARS-CoV-2 virus in various regions of the
world during the Covid-19 pandemic is essential to help mitigate the effects of
this devastating disease. We describe the phylogenomic and population genetic
patterns of the virus in Mexico during the pre-vaccination stage, including
asymptomatic carriers. A real-time quantitative PCR screening and phylogenomic
reconstructions directed at sequence/structure analysis of the spike glycoprotein
revealed mutation of concern E484K in genomes from central Mexico, in addition to
the nationwide prevalence of the imported variant 20C/S:452R (B.1.427/9).
Overall, the detected variants in Mexico show spike protein mutations in the
N-terminal domain (i.e. R190M), in the receptor-binding motif (i.e. T478K,
E484K), within the S1-S2 subdomains (i.e. P681R/H, T732A), and at the basis of
the protein, V1176F, raising concerns about the lack of phenotypic and clinical
data available for the variants of interest we postulate: 20B/478K.V1 (B.1.1.222 
or B.1.1.519) and 20B/P.4 (B.1.1.28.4). Moreover, the population patterns of
single nucleotide variants from symptomatic and asymptomatic carriers obtained
with a self-sampling scheme confirmed the presence of several fixed variants, and
differences in allelic frequencies among localities. We identified the mutation
N:S194L of the nucleocapsid protein associated with symptomatic patients.
Phylogenetically, this mutation is frequent in Mexican sub-clades. Our results
highlight the dual and complementary role of spike and nucleocapsid proteins in
adaptive evolution of SARS-CoV-2 to their hosts and provide a baseline for
specific follow-up of mutations of concern during the vaccination stage.

DOI: 10.1099/mgen.0.000684 
PMID: 34846283 

